In parallel, JAK1 and JAK2 hyperactivation is commonly linked to cytokine-driven signaling that sustains tumor growth, while TYK2 shows dual behavior: supporting immune surveillance in some contexts but fostering immune evasion in others. The gene discussed is TYK2; the disease is neoplasm.